Media Center

News

All | NTI and technological development | Investments

An RVC Biofund Portfolio Company's Development to Detect Lung Damage in COVID-19 Patients Was Successfully Tested
An RVC Biofund Portfolio Company's Development to Detect Lung Damage in COVID-19 Patients Was Successfully Tested

Press about RVC

All | RVC | Investments | NTI

Scientific Inventions Are for Business
27.11.2020
A lot of work needs to be done to transform cutting-edge scientific research into technologies ready for implementation. Scientists themselves are not always capable of this, if only because they do not know many features of production or business processes. And engineers in companies that are precisely engaged in adapting technologies to reality may not be aware of scientific developments' intricacies. It's a good idea to join forces. This was done in Russia.
RVC and Chinese DeepBlue Technology Corporation To Develop Projects For Smart Cities
02.11.2020
Russian Venture Company (RVC) and the Chinese corporation DeepBlue Technology will be engaged in the development of technological projects in the field of smart cities and Industry 4.0 (artificial intelligence and robotization, the Internet of Things, 3D printing, virtual and augmented reality, bio- and neurotechnologies), RVC said in a statement.
Scientific Inventions Are for Business
27.11.2020
A lot of work needs to be done to transform cutting-edge scientific research into technologies ready for implementation. Scientists themselves are not always capable of this, if only because they do not know many features of production or business processes. And engineers in companies that are precisely engaged in adapting technologies to reality may not be aware of scientific developments' intricacies. It's a good idea to join forces. This was done in Russia.
Artur Isaev Buys Out a Share of the Genetico Laboratory Network from the RVC Biofund
26.11.2020
Artur Isaev, the founder of the Human Stem Cells Institute (HSCI), bought out a 17.79% share of Russian Venture Company's (RVC's) biofund in the HSCI portfolio company, the Genetico laboratory network. The details of the transaction were not disclosed; it is known, however, that the biofund has invested about 180 million roubles since 2014, and the transaction was profitable for RVC, the Company said.
Venue: